Pulmonary fibrosis in a patient treated with erlotinib.
Bach
Jan-Philipp
JP
Kiessling
Andreas M
AM
Kleinhans
Antje
A
Faoro
Charis
C
Gorg
Christian
C
Riera-Knorrenschild
Jorge
J
Schwella
Nimrod
N
Wagner
Hans-Joachim
HJ
Neubauer
Andreas
A
D000328:Adult; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy*; D000069347:Erlotinib Hydrochloride; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male; D047428:Protein Kinase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D011658:Pulmonary Fibrosis / Q000139:chemically induced* / Q000175:diagnosis*; D011799:Quinazolines / Q000009:adverse effects* / Q000627:therapeutic use
D000970:Antineoplastic Agents; D047428:Protein Kinase Inhibitors; D011799:Quinazolines; D000069347:Erlotinib Hydrochloride